Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
H7 BioCapital is a venture capital firm based in Silicon Valley, established to focus on life science investments and business development within the pharmaceutical industry. The firm is dedicated to advancing healthcare innovation through targeted investments in therapeutics and medtech. H7 BioCapital operates with a clear mission to support high-potential startups in the life sciences sector.
Currently, H7 BioCapital runs a healthcare accelerator program that provides mentorship, funding, and educational resources to emerging biotech, medtech, and device startups. The firm utilizes Special Purpose Vehicles (SPVs) to facilitate investments, although specific quantitative metrics such as fund size and team size are not disclosed. H7 BioCapital's commitment to healthcare innovation positions it as a key player in the life sciences investment landscape.
H7 BioCapital primarily invests in the life sciences sector, with a strong emphasis on therapeutic companies that are in IND-enabling or clinical development stages. The firm also targets medtech companies that have achieved post-revenue status or have been clinically validated. This dual focus allows H7 BioCapital to engage with a diverse range of startups that are poised for growth and innovation in healthcare.
The firm operates an angel syndicate that invests through Special Purpose Vehicles (SPVs), enabling them to support high-potential life science and medtech companies from seed to pre-IPO stages. Additionally, H7 BioCapital's three-month healthcare accelerator program is designed to provide startups with essential mentorship, funding, and educational support, further enhancing their chances of success in the competitive life sciences market.
Submit your pitch through their website's contact form for consideration.
H7 BioCapital runs a three-month healthcare accelerator program aimed at supporting biotech, medtech, and device startups. This program offers mentorship, funding, and educational resources to help startups navigate the complexities of the life sciences sector.
Startups interested in participating in the accelerator program should inquire directly with H7 BioCapital for eligibility criteria and application details.
What are H7 BioCapital's investment criteria?
H7 BioCapital focuses on life sciences investments, particularly in therapeutic companies in IND-enabling or clinical development, and medtech companies that are post-revenue or clinically validated.
How can startups apply for funding?
Startups interested in funding from H7 BioCapital should reach out through their healthcare accelerator program, which provides mentorship and funding opportunities.
What makes H7 BioCapital different from other venture firms?
H7 BioCapital distinguishes itself by its dedicated focus on life sciences and its operational support through an accelerator program that offers mentorship and educational resources.
What is the geographic scope of H7 BioCapital's investments?
The firm primarily invests in North America, targeting innovative startups within the life sciences sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, H7 BioCapital invests in companies from seed to pre-IPO stages, indicating a range of investment amounts based on the startup's development stage.
What kind of post-investment involvement does H7 BioCapital have?
H7 BioCapital actively engages with its portfolio companies through mentorship and support provided in their accelerator program, enhancing the growth potential of their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.